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SUMMARY
Objective: This study aims to evaluate the outcome of AKI patients caused by acute 
tubular necrosis admitted in clinical and surgical units of Botucatu Medical School Uni-
versity Hospital - Unesp.  Methods: This is a retrospective cohort study with 477 adult 
patients were observed from January 2001 to December 2008. AKI was defined accord-
ing to serum creatinine levels as proposed by Acute Kidney Injury Network (AKIN). 
Results: The mean age was 65.5 ± 162 years. The majority of the patients were males 
(62%) older than 60 years (65.2%). Diabetes mellitus was diagnosed in 61.9%, high blood 
pressure in 44.4% and chronic kidney disease 21.8% of the patients. Death occurred 66% 
of dialysis requirement, critical care unit admission, age > 60 years and lower attendance 
time by nephrologists were significant and independently associated with death risk. 
The renal recorery among survivors was of 96.9%. Conclusion: This work shows that 
the evolution of AKI patients from clinical and surgical wards is similar to literature. 
However, the high mortality of the group shows the necessity of identifying risk factors 
for the development of AKI in these patients and training staff assistant for the early 
diagnosis of this syndrome.
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INTRODUCTION
Acute kidney injury (AKI) is characterized by a rapid fall in 
glomerular filtration rate, accompanied or not by nitrogen 
product retention and water-electrolyte disturbances1,2. It 
is a complex pathology with multiple and varied etiologies 
and with no consensus definition3. Currently, classifications 
based on increased blood creatinine and urine output fall, 
such as RIFLE1 and AKIN4, are used.
Several studies show the incidence of this syndrome 
has increased over the last decades, being associated with 
a longer life expectancy and multiple comorbidities in the 
population5,6.
AKI is less frequent in the community (0.4% to 0.9%) 
than in hospitalized patients (4.9% to 7.2%)7,8. In hospitals, 
AKI becomes an important complication when associated 
with the number and severity of comorbidities experienced 
by the patients, occurring in a rate around 20% to 40% in In-
tensive Care Units (ICU) and around 1% to 7% in interme-
diate care units2,3. According to Lameire et al.6, 5% to 20% 
of patients in ICUs experience at least one episode of AKI 
associated with multisystem organ failure.
The identification of risk factors associated with AKI 
and its poor prognosis is required so that preventive and 
early diagnosis measures can be taken, aiming to reduce pa-
tients’ mortality9,10.
Several authors assessed the main AKI risk factors, being 
hospitalized patients, old age, chronic kidney disease, sepsis 
and heart surgeries the most usually found, among others10-14.
Liangos et al.14 found in a study with a great number of 
in-patients that chronic diseases, such as diabetes mellitus 
(DM), high blood pressure (HBP), coronary artery disease, 
congestive heart failure, neoplasms and HIV infection were 
associated with a higher risk to develop AKI and conse-
quently a higher mortality. In contrast, other studies suggest 
AKI mortality is not associated with preexisting chronic 
diseases, such as HBP, DM or chronic obstructive pulmo-
nary disease (COPD), but rather with clinical events over 
the hospitalization, such as dialysis requirement, oliguria 
and one or more organ failure10-12.
This work aimed to study patients surviving AKI and 
proceeding from medical and surgical wards in regard to 
their clinical and laboratorial characteristics, risk factors as-
sociated with death, and recovery of kidney function.
METHODS
This is a retrospective cohort study of patients with AKI 
from acute tubular necrosis (ATN). They were admitted to 
internal medicine and surgical gastroenterology wards at 
the University Hospital of the Medical School of Botucatu 
– Unesp – attended by the AKI Group of the Discipline 
of Nephrology from January 2001 to December 2008. Pa-
tients with age under 18 years, having chronic kidney fail-
ure (CKF) and those undergoing kidney transplantation 
were excluded.
CKF was defined as the presence of a baseline serum 
creatinine > 1.4 mg/dL. AKI was defined as proposed by 
the Acute Kidney Injury Network (AKIN)4, while ATN 
represented a pathological term meaning the kidney tu-
bule cell necrosis triggered by either ischemic and/or 
nephrotoxic injury15.
In the initial nephrologist’s assessment, ATN-ISS16, a 
specific prognosis index for ATN patients, was used.
The patients were followed-up until either the dis-
charge from nephrology service or the death.
This study was submitted to the Research Ethics Commit-
tee, Medical School of Botucatu, approved in April 7, 2008
STATISTICAL ANALYSIS
Initially, a patient descriptive analysis was conducted, 
with central tendency and dispersion measurements be-
ing calculated for continuous variables and frequency for 
categorical variables. The occurrence of death was set as a 
dependent variable, with the chi-squared test being used 
for categorical variables, while the T Test (for a parametric 
distribution) and the Mann-Whitney Test (for nonpara-
metric distribution) were used for continuous variables. 
The following step was to conduct a multivariate analysis 
by the logistic regression model with odds ratio (OR) cal-
culation. All variables showing to be associated with the 
end-point (p  0.20) were included in the analysis. Statisti-
cal soware, SPSS version 15.0, was used for the calcula-
tion, with a statistical significance 5% (p  0.05).
RESULTS
Four hundred seventy-seven patients diagnosed with AKI 
were studied. Table 1 shows clinical and laboratorial char-
acteristics in this population. Males were predominant 
(62%). The mean age was 65.5  ±  16.2 years, with 65.2% 
older than 60. Regarding comorbidities, 61.9% (out of 426 
patients) had DM; 44.4% had HBP and 21.9% (out of 375) 
had CKF. The median baseline creatinine was 1.1  mg/dL 
(interquartile range: 0.9-1.5  mg/dL). Among the patients, 
78.2% were in an ICU and sepsis was diagnosed in 64.4% 
of patients. The median first elevated serum creatinine a±er 
admission was 2.4  mg/dL (1.7-3.5  mg/dL), while the me-
dian serum creatinine at the first nephrologist’s evaluation 
was 3.3 mg/dL (2.4-4.6 mg/dL). The median time between 
the first elevated serum creatinine a±er the admission and 
the nephrologist’s evaluation was 3 days (1-7), while the me-
dian time of nephrological follow-up was 5 days (2-11). The 
median ATN-ISS was 0.64 (0.39-0.8). Ischemic AKI had a 
higher frequency, occurring in 65% of cases. Urine output 
was present in 58.9% of patients. Dialysis was carried out in 
36.5% of cases, with hemodialysis predominating (70.1%). 
The overall mortality was 66%. Out of 162 surviving pa-
tients, 96.9% had a complete or a partial recovery of kidney 
function, with a median nephrological follow-up time of 7 
days (4-14.5), while 3.1% continued on chronic dialysis.
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Tables  1 and 2 describe clinical and laboratorial vari-
ables associated with death in patients with AKI diagnosed.
In univariate analysis, age over 60 years (survi-
vors  =  58.5%; non-survivors  =  68.7%; p  =  0.034), pres-
ence of CKF (33.6 and 15.2%; p < 0.0001), baseline serum 
creatinine (median, 1.2 and 1.1 mg/dL; p < 0.0001), ICU 
admission (60.9 and 87.2%; p < 0.0001), presence of sepsis 
(44.5 and 74.8%; p < 0.0001) and nephrological follow-up 
time (median 7 and 3 days; p < 0.0001) were significantly 
different. The non-survivors showed a higher percentage 
of mixed type AKI (36.7 and 15.8%) and a lower percent-
age of ischemic (60 and 74.4%) and nephrotoxic (3.3 and 
9.8%) AKI (p  <  0.001), lower presence of urine output 
(44.7 and 86%; p  <  0.0001) and higher dialysis require-
ment (45 and 20.1%; p < 0.0001).
In multivariate analysis, dialysis requirement 
(OR = 3.65; 95% CI = 1.65–8.08; p = 0.001), ICU admis-
sion (3.10; 1.56-6.08; p = 0.001), age over 60 years (1.06; 
1.55-5.35; p = 0.001) and shorter nephrological follow-up 
time (1.05; 1.01–1.08; p = 0.002) were variables associated 
with death, while nephrotoxic type AKI (0.40; 0.20-0.77; 
p = 0.006) and presence of urine output (0.16; 0.08–0.31; 
p < 0.0001) were associated with lower mortality.
DISCUSSION
This study investigated a cohort of patients admitted to medi-
cal and surgical wards with a diagnosis of AKI from ATN 
over a period of eight years; clinical and laboratory charac-
teristics were similar to those in other papers10,12-14. There was 
a predominance of males, elderly and the presence of comor-
bidities, such as DM, HBP and CKF. Similar outcomes were 
obtained by Liangos et al.14 and Leblanc et al.13, whereas Nash 
et al.17 observed, in a study with 4,622 patients admitted to 
medical and surgical services, that age over 80 years, male 
gender and high serum creatinine levels at the hospital ad-
mission were associated with a higher AKI risk.





Age (years)* 65.5 ± 16.2




Baseline serum creatinine (mg/dL)** 1.1 (0.9-1.5)
Admitted to ICU (%) 78.2
Sepsis present (%) 64.4
1st elevated serum creatinine after admission (mg/dL) ** 2.4 (1.7-3.5)
Serum creatinine at the 1st nephrologist’s evaluation (mg/dL) ** 3.3 (2.4-4.6)
Time between the 1st elevated serum creatinine and the first nephrologist’s 
evaluation (days)**
3 (1-7)
ATN-ISS ** 0.64 (0.39-0.8)





Urine output present (%) 58.9





Kidney recovery among survivors (%)
Recovery 96.9
Chronic dialysis 3.1
Cr, creatinine; AKI, acute kidney injury; DM, diabetes mellitus; HBP, high blood pressure; CKF, chronic kidney failure. Number of patients 
evaluated according to certain variables: DM = 426; CKF = 375.
* Mean and standard deviation
** Median and interquartile range
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ICU admission and the presence of sepsis were pre-
dominant characteristics in this study patients. According 
to the literature, 5% to 20% of patients considered as hav-
ing a critical illness develop AKI over the courde of the ill-
ness, accompanied, in many cases, by multisystem organ 
failure11,18,19. Schrier et al.20 showed a relationship between 
sepsis severity and AKI, with the later present in 19% of pa-
tients with moderate sepsis, in 23% with severe sepsis and in 
51% with septic shock. In a prospective multicenter study, 
Uchino et al.21 found an AKI incidence in 5.7% of patients 
admitted to an ICU, with sepsis being its main cause.
This study shows patients had a median baseline creatinine 
of 1.1 mg/dL, while the median first elevated creatinine af-
ter admission was 2.4 mg/dL and the first nephrological 
evaluation occurred only with the median serum creati-
nine 3.3 mg/dL, suggesting a delay in AKI diagnosis by the 
team or a di culty in rating the case severity, not valuating 
the serum creatinine levels obtained. Chertow et al.5 dem-
onstrated small increments in serum creatinine are signifi-
cantly associated with increased mortality in patients with 
AKI. Lameire et al.6 reported only 22% of patients devel-
oping AKI are referred to a nephrologist.





(n = 315) p value
Males (%) 60.9 62.6 0.80
Age (years) ** 68 (51.5-78) 69 (58-76.3) 0.37
Age > 60 years (%) 58.5 68.7 0.034
DM (%) 64.7 60.4 0.42
HBP (%) 50.6 41.2 0.06
CKF (%) 33.6 15.2 < 0.0001
Baseline serum creatinine (mg/dL) ** 1.2 (1.0-1.7) 1.1 (0.9-1.3) < 0.0001
Admitted to ICU (%) 60.9 87.2 < 0.0001
Presence of sepsis (%) 44.5 74.8 < 0.0001
1st elevated serum Cr after admission (mg/dL)** 2.7 (1.7-3.6) 2.3 (1.7-3.3) 0.055
Serum Cr at the 1st nephrologist’s evaluation (mg/dL)** 3.15 (2.3-4.4) 3.4 (2.5-4.6) 0.224
Time between the 1st elevated serum creatinine after 
admission and the 1st nephrologist’s evaluation (days)
2.3 (1-5.5) 3 (1-8) 0.17
ATN-ISS * * 0.6  (0.33-0.8) 0.67 (0.43-0.8) 0.062
Nephrological follow-up time (days)** 7 (4-14.5) 3 (1-9)  < 0.0001
AKI type (%)
Ischemic 74.4 60
< 0.0001Nephrotoxic 9.8 3.3
Mixed 15.8 36.7
Presence of urine output (%) 86 44.7 < 0.0001




Peritoneal dialysis 39.4 27.6
Cr, creatinine; AKI, acute kidney injury; DM, diabetes mellitus; HBP, high blood pressure; CKF, chronic kidney failure ** Median and interquartile 
range.
Table 3 – Multivariate analysis of clinical and laboratory variables related to death in patients with AKI diagnosed
Variables Estimate of effect p value OR CI (OR;95%)
Dialysis requirement 1.29 0.001 3.65 1.65 8.08
ICU admission 1.13 0.001 3.10 1.57 6.08
Age > 60 years 1.06 0.001 2.88 1.55 5.35
Nephrological follow-up time (days) 0.04 0.002 1.05 1.01 1.08
Nephrotoxic AKI - 0.91 0.006 0.40 0.20 0.77
Presence of urine output -1.79 0.000 0.16 0.08 0.31
Constant -1.67 0.000 0.18
X2 = 57.00; gImodel = 9; p < 0.001; n = 294
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In this study, the median ATN-ISS was 0.64, very 
similar to the mortality in the general population (66%), 
suggesting a good association between this score and the 
mortality in patients followed. This data is consistent with 
that reported by Balbi et al.22, which upon demonstrating 
a good calibration, mainly from the third quintile, and an 
excellent discrimination, with an area under curve of 0.95, 
concluded this prognosis index shows great reliability to 
be applied in the nephrologist’s daily practice.
The percentage of deaths in the population was gener-
ally similar to data found in the current literature, being 
high because the patients were in critical condition, most 
of them admitted to an ICU. In studies investigating popu-
lations in a less critical condition, Silvester et al.23 found a 
mortality of 46.8%, Sesso et al.24 found 54% and, in Botu-
catu, Balbi et al.22 and Valente et al.25 found mortality rates 
of 44.3% and 40.2%, respectively, in different periods.
Age19,26-28, admission prognosis scores18,19,27,28 and sep-
sis28,29 have been classical factors associated with death. In 
this study, a  er multivariate analysis, dialysis requirement, 
ICU admission, age over 60 years and a shorter nephro-
logical follow-up time were associated with death, whereas 
nephrotoxic type AKI and the presence of urine output 
were factors associated with a lower mortality. Mortality 
from AKI varies as a function of the severity of the pa-
tient’s case and, as result, of the facility where the patient 
was admitted11,30. Liaño et al.31 observed patients coming 
out of an ICU had a mortality of 69.6%, whereas in the 
wards the variation was 36.3% (medical wards) and 42.8% 
(surgical wards). The elevated mortality in patients admit-
ted to an ICU is also associated with clearly known poor 
clinical factors, such as hypotension32, jaundice32,33, coma16, 
sedation16 and oliguria16,30,34.
As shown in this and in other studies, sepsis is a fac-
tor clearly associated with increased death risk in patients 
with AKI18,34. According to Edelstein et al.35, a combina-
tion of AKI and sepsis is associated with a 70% mortality, 
compared to a 45% mortality in patients with AKI alone. 
Neveu et al.34, in a prospective study involving 345 patients 
having AKI with and without sepsis, showed a great dif-
ference in mortality (74.5% with sepsis and 45.2% without 
sepsis; p < 0.001).
Concerning clinical AKI characteristics, this study 
shows reduced urine output and dialysis requirement 
were associated with a higher mortality. As suggested by 
evidence, nonoliguric AKI has a better prognosis than oli-
guric AKI, and this latter is one of the main prognosis fac-
tors of mortality, once no urine output is associated with 
more kidney impairment and, as a result, a poorer clini-
cal course18,34,36,37. Regarding dialysis requirement, Mehta 
et al.38, in a recent study with ICU patients, showed a sig-
nificantly lower mortality in patients who had nondialytic 
AKI compared with those undergoing dialysis (24% and 
45%, respectively). Balbi et al.22 observed that in patients 
requiring dialysis, the mortality was 63.8%, much higher 
than that found in patients undergoing only conservative 
treatment (23.5%; p < 0.05). Other studies apart from this 
show that requiring dialysis is a death risk factor in pa-
tients with AKI18,31,34,39.
CONCLUSION
This study shows, in a cohort with 477 patients diagnosed 
with AKI and admitted to medical and surgical wards, that 
the syndrome course is similar to the date obtained from the 
literature, with high mortality, classical risk factors associ-
ated with mortality and elevated kidney function recovery 
among survivors. The high mortality in the group shows 
the identification of risk factors for AKI development in 
these patients and an attending team skilled to diagnose 
this syndrome early are the key for a good outcome.
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